Edition:
United States

Alliance Pharma PLC (ALAPH.L)

ALAPH.L on London Stock Exchange

46.88GBp
24 Mar 2017
Change (% chg)

-0.38 (-0.79%)
Prev Close
47.25
Open
48.00
Day's High
48.50
Day's Low
46.75
Volume
285,559
Avg. Vol
608,083
52-wk High
54.50
52-wk Low
40.50

ALAPH.L

Chart for ALAPH.L

About

Alliance Pharma plc is a United Kingdom-based specialty pharmaceutical company. The Company is engaged in acquisition, marketing and distribution of pharmaceutical products. The Company operates in various business areas, such as Hydromol, secondary care, community and consumer products, established products and international.... (more)
No analyst recommendations are available for ALAPH.L.

Overall

Beta: --
Market Cap(Mil.): --
Shares Outstanding(Mil.): 14.96
Dividend: --
Yield (%): --

Financials

  ALAPH.L Industry Sector
P/E (TTM): -- 29.17 29.94
EPS (TTM): -- -- --
ROI: -5.16 13.48 13.01
ROE: -5.16 14.39 14.16

BRIEF-Alliance Pharma updates on settlement agreement with Sinclair Pharma

* Reached agreement with Sinclair Pharma for compensation in connection with material reduction of business in Kelo-Stretch™

Mar 21 2017

BRIEF-Alliance Pharma names exec director Butterfield as deputy CEO

* Peter Butterfield, an executive director of company, is appointed deputy CEO with immediate effect Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +91 806 749 1136)

Oct 28 2016

More From Around the Web

Earnings vs. Estimates

No consensus analysis data available.